Proliferation of abnormal bone marrow histiocytes, an undesired effect of granulocyte macrophage-colony-stimulating factor therapy in a patient with hurler's syndrome undergoing bone marrow transplantation
Authors:
- Michael L. CibullMCMichael L. Cibull
- Diane D. DaveyDDDiane D. Davey
- Vincent S. GallicchioVGVincent S. Gallicchio
- P. Jean Henslee-DowneyPHP. Jean Henslee-Downey
- Edward J. HarderEHEdward J. Harder
- 1 December 1992
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 41 (4) , 280-284
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantationBlood, 1990
- Hematopoietic Growth FactorsNew England Journal of Medicine, 1989
- In Vitro Effect of Lithium on Carbamazepine-Induced Inhibition of Murine and Human Bone Marrow-Derived Granulocyte-Macrophage, Erythroid, and Megakaryocyte Progenitor Stem CellsExperimental Biology and Medicine, 1989
- Hematophagic HistiocytosisMedicine, 1988
- Reactive histiocytic hyperplasia with hemophagocytosis in hematopoietic organs: A reevaluation of the benign hemophagocytic proliferationsHuman Pathology, 1988
- The Application of Bone Marrow Transplantation to the Treatment of Genetic DiseasesScience, 1986
- Bacteria-associated hemophagocytic syndromeCancer, 1984
- REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATIONThe Lancet, 1981
- Morphologic alterations in nucleated blood and marrow cells in genetic disordersHuman Pathology, 1970